ABL Bio Inc (298380) — Financial Flexibility Index
ABL Bio Inc (298380) has a Financial Flexibility Index of -0.23x as of June 2026. Free cash flow of ₩-22.86 Billion (operating CF ₩-23.42 Billion minus capex ₩552.62 Million) represents 0% of total liabilities (₩99.78 Billion). Check 298380 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ABL Bio Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for ABL Bio Inc across 10 annual periods. For the full cash flow conversion analysis, see cash flow conversion of ABL Bio Inc.
Annual Financial Flexibility Index for ABL Bio Inc (2016–2025)
Year-by-year free cash flow to debt coverage for ABL Bio Inc. Explore 298380 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.17x | ₩-20.58 Billion | ₩-41.25 Billion | ₩124.24 Billion | ▲ +82.2% |
| 2024 | -0.93x | ₩-60.34 Billion | ₩-69.40 Billion | ₩64.70 Billion | ▼ -256.5% |
| 2023 | -0.26x | ₩-22.52 Billion | ₩-28.36 Billion | ₩86.07 Billion | ▼ -140.8% |
| 2022 | 0.64x | ₩74.19 Billion | ₩72.13 Billion | ₩115.67 Billion | ▲ +115.5% |
| 2021 | -4.14x | ₩-39.36 Billion | ₩-40.61 Billion | ₩9.50 Billion | ▲ +18.4% |
| 2020 | -5.08x | ₩-46.86 Billion | ₩-47.29 Billion | ₩9.23 Billion | ▼ -148.4% |
| 2019 | -2.04x | ₩-22.26 Billion | ₩-23.86 Billion | ₩10.89 Billion | ▼ -111.3% |
| 2018 | -0.97x | ₩-11.52 Billion | ₩-12.67 Billion | ₩11.91 Billion | ▼ -1522.3% |
| 2017 | -0.06x | ₩-6.34 Billion | ₩-7.14 Billion | ₩106.32 Billion | ▼ -18.7% |
| 2016 | -0.05x | ₩-985.97 Million | ₩-3.12 Billion | ₩19.63 Billion | — |